Background The intrathecally administered antisense oligonucleotide tofersen reduces
synthesis of the superoxide dismutase 1 (SOD1) protein and is being studied in patients with …

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is characterized
by the degeneration of both upper and lower motor neurons, which leads to muscle …

Background Few patients with amyotrophic lateral sclerosis currently receive non-invasive
ventilation (NIV), reflecting clinical uncertainty about the role of this intervention. We aimed to …

Objective Amyotrophic lateral sclerosis (ALS) is a common, fatal motor neuron disorder with
no effective treatment. Approximately 10% of cases are familial ALS (FALS), and the most …

Amyotrophic lateral sclerosis is a fatal CNS neurodegenerative disease. Despite intensive
research, current management of amyotrophic lateral sclerosis remains suboptimal from …

The application of human embryonic stem cells (HESCs) to provide differentiated cells for
regenerative medicine will require the continuous maintenance of the undifferentiated stem …

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterized
by death of motor neurons leading to muscle wasting, paralysis, and death, usually within …

Amyotrophic lateral sclerosis (ALS) is a genetically diverse disease. At least 15 ALS-associated
gene loci have so far been identified, and the causative gene is known in approximately …

Background and Purpose— “Incidental” MRI white matter (WM) lesions, comprising periventricular
lesions (PVLs) and deep subcortical lesions (DSCLs), are common in the aging brain. …

Two decades after the discovery that 20% of familial amyotrophic lateral sclerosis (ALS)
cases were linked to mutations in the superoxide dismutase-1 (SOD1) gene, a substantial …